Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herombopag and Cyclosporine in Non-Severe Aplastic Anemia
NCT05660785Phase 2Completed
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Dec 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hetrombopag in aplastic anemia, sponsored by Institute of Hematology and Blood Diseases Hospital. Started Dec 2022; status: completed.
02
Drugs
hetrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT05660785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05660785.